Premarin and Genvoya drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Premarin (estrogens, conjugated) and Genvoya (cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate). Common drug interactions include osteoporosis among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Premarin and Genvoya. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Premarin?

Premarin has active ingredients of estrogens, conjugated. It is often used in hormone replacement therapy. eHealthMe is studying from 99,630 Premarin users. Check the latest studies of Premarin.

What is Genvoya?

Genvoya has active ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 13,538 Genvoya users. Check the latest studies of Genvoya.



On Jul, 19, 2026

20 people who take Premarin and Genvoya together, and have interactions are studied.

Premarin and Genvoya drug interactions.

What are the common drug interactions of Premarin and Genvoya, by gender? *:

female:

  1. Osteoporosis (bones weak and more likely to break)
  2. Chronic kidney disease
  3. Foot fracture
  4. Bone density decreased
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Multiple fractures
  7. Ankle fracture
  8. Hypertension (high blood pressure)
  9. Pain in extremity
  10. Asthenia (weakness)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Emotional distress
  5. Foot fracture
  6. Pain

What are the common drug interactions of Premarin and Genvoya, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Ankle fracture
  2. Foot fracture
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Emotional distress
  6. Pain
  7. Back injury
  8. Bone density decreased
  9. Osteopenia (a condition where bone mineral density is lower than normal)
  10. Osteoporosis (bones weak and more likely to break)

50-59:

  1. Chronic kidney disease
  2. Foot fracture
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Emotional distress
  6. Pain
  7. Asthenia (weakness)
  8. Bone density decreased
  9. Multiple fractures
  10. Osteopenia (a condition where bone mineral density is lower than normal)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Arthralgia (joint pain)
  3. Pain
  4. Pain in extremity
  5. Cd4 lymphocytes decreased
  6. Back pain
  7. Bone density decreased
  8. Chronic kidney disease
  9. Emotional distress
  10. Foot fracture

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.00%
  2. High Blood Pressure: 3 people, 15.00%
  3. Vaginal Infection: 2 people, 10.00%
  4. Skin Papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections): 2 people, 10.00%
  5. Asthma: 2 people, 10.00%
  6. Calcium Deficiency (lack of calcium): 2 people, 10.00%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 10.00%
  8. Constipation: 2 people, 10.00%
  9. Cough: 2 people, 10.00%
  10. Depression: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Premarin and Genvoya?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Premarin and Genvoya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Premarin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Genvoya:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Premarin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Genvoya and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on estrogens, conjugated and cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Premarin and Genvoya, respectively), and Premarin and Genvoya (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: